ROGER NGAHA: Open Payments
NPI 1134869886 · BEAUMONT, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$421 in 20 payments from 5 companies in 2025. Trend: 2023 $20 · 2024 $41 · 2025 $421
Food & beverage: $421
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 8 | $169 |
| Janssen Pharmaceuticals, Inc | 4 | $82 |
| Alkermes, Inc. | 4 | $81 |
| ABBVIE INC. | 3 | $74 |
| Luye Pharma (USA) Ltd. | 1 | $14 |
Products named: AUSTEDO XR, INVEGA SUSTENNA, ARISTADA, VRAYLAR, UZEDY, ERZOFRI EXTENDED-RELEASE.
Industry payments across CA — which companies pay providers there.
